DOJ, SEC Investigating GlaxoSmithKline for Possible FCPA Violations
By Mary Jacoby | August 13, 2010 12:21 pm

The Justice Department and Securities and Exchange Commission are investigating the pharmaceutical giant, GlaxoSmithKline, for possible violations of the Foreign Corrupt Practices Act, the Financial Times reported.

It has been known for months that the DOJ’s Criminal Fraud Section and the SEC are investigating several pharmaceutical companies for potential FCPA violations. But it has not been publicly known that Glaxo Smith Kline was one of companies under scrutiny.

In April, the DOJ and SEC sent letters to at least five other major pharmaceutical companies: AstraZeneca PLC; Baxter International Inc.; Eli Lilly & Co.; Bristol-Myers Squibb Co.; and Merck & Co

The letters, which were later described to Main Justice, said the agencies were focusing on the companies’ business in several countries, which varied by firm but included Brazil, China, Germany, Greece, Italy, Poland, Russia and Saudi Arabia.

GlaxoSmithKline told FT that it had received “inquiries” from US authorities, but that it disclosed the issue only “reactively,” telling only a few reporters in April. However, the inquiry into the company was not disclosed in news reports at the time.

An industry attorney familiar with the probe told FT the Justice Department was looking at whether the companies had ignored a “systematic risk” inherent in the global drugs business, though it is not clear precisely what activity is under investigation.

Facebook Twitter Linkedin Email

61 Comments

  1. Anderson says:

    …Check this out…

    [...]Wow, superb weblog structure! How lengthy have you ever been running a blog for?[...]…

  2. NBA Picks says:

    [...]the time to read or visit the content or sites we have linked to below the[...]……

    [...]here are some links to sites that we link to because we think they are worth visiting[...]……

  3. modele photo says:

    Trackback…

    [...]The total glance of your site is great, let smartly as the content![...]…

  4. bike games says:

    Websites we think you should visit…

    [...]although websites we backlink to below are considerably not related to ours, we feel they are actually worth a go through, so have a look[...]……

  5. tatuaggi says:

    Blogs ou should be reading…

    [...]Here is a Great Blog You Might Find Interesting that we Encourage You[...]……

Leave a Comment

You must be logged in to post a comment.

Ernst & Young LLP
Dealing with complex issues of fraud, regulatory compliance and business disputes can detract from efforts to succ... more
Barnes & Thornburg LLP
ANALYSIS: Dodd-Frank Whistleblower Litigation Heating Up more
Clifford Chance
ANALYSIS: A Safe Haven from Which to Plan Foreign Bribes - The Lack of Extra-Territoriality of Hong Kong's Anti-Br... more
Paul Hastings LLP
ANALYSIS: Legislative Reform of China's Healthcare Sector Targets Corruption: Implications for Multinational Compa... more
Debevoise & Plimpton LLP
ANALYSIS: The SEC Noble Prosecution: Takeaways from the O’Rourke, Jackson and Ruehlen Settlements  more
Ropes & Gray LLP
ANALYSIS: Smith & Wesson May Establish New Claim for Insufficient Compliance Program. more
Carlton Fields Jorden Burt
ANALYSIS: The Pros and Cons of Client Proffer Letters - Should You Talk to the Government? more

LUKE RUSSERT INTERVIEWS MARY JACOBY ABOUT CHRIS CHRISTIE INVESTIGATION: The Main Justice editor in chief appeared on MSNBC to discuss the one-year anniversary of the closings of the George Washington Bridge lanes.